Trial intelligence / Profile preview

HEART: Agalsidase Beta in Female Fabry Patients

NCT00487630Phase 4Unknown

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2005
Modality
Replacement Enzymes
Countries
1
01

Overview

A Phase 4 trial of agalsidase beta in Fabry disease (FD), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.

02

Drugs

agalsidase beta
03

Conditions

Fabry disease (FD)

Beyond the preview

Go deeper on NCT00487630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00487630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call